BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24393554)

  • 1. Intestinal ischemia-reperfusion suppresses biliary excretion of hepatic organic anion transporting polypeptides substrate.
    Maruyama H; Ogura J; Fujikawa A; Terada Y; Tsujimoto T; Koizumi T; Kuwayama K; Kobayashi M; Yamaguchi H; Iseki K
    J Pharm Pharm Sci; 2013; 16(5):722-31. PubMed ID: 24393554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of oral and intravenous administration of digoxin after intestinal ischemia-reperfusion.
    Ogura J; Maruyama H; Kobayashi M; Itagaki S; Iseki K
    Biol Pharm Bull; 2010; 33(5):922-5. PubMed ID: 20460779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oxidative stress on expression and function of human and rat organic anion transporting polypeptides in the liver.
    Tsujimoto T; Ogura J; Kuwayama K; Koizumi T; Sasaki S; Terada Y; Kobayashi M; Yamaguchi H; Iseki K
    Int J Pharm; 2013 Dec; 458(2):262-71. PubMed ID: 24409515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of hepatic transporters for BSP in rats with indomethacin-induced intestinal injury.
    Fujiyama N; Shitara Y; Ito K; Masubuchi Y; Horie T
    Biol Pharm Bull; 2007 Mar; 30(3):556-61. PubMed ID: 17329856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats.
    Schneider R; Sauvant C; Betz B; Otremba M; Fischer D; Holzinger H; Wanner C; Galle J; Gekle M
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1599-605. PubMed ID: 17244891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
    Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y
    Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (Oatps).
    Cheng X; Maher J; Chen C; Klaassen CD
    Drug Metab Dispos; 2005 Jul; 33(7):1062-73. PubMed ID: 15843488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired Transport Activity of Human Organic Anion Transporters (OATs) and Organic Anion Transporting Polypeptides (OATPs) by Wnt Inhibitors.
    Ali Y; Shams T; Cheng Z; Li Y; Chun CS; Shu W; Bao X; Zhu L; Murray M; Zhou F
    J Pharm Sci; 2021 Feb; 110(2):914-924. PubMed ID: 33049263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of bile salt and organic anion transporters in developing rat liver.
    Gao B; St Pierre MV; Stieger B; Meier PJ
    J Hepatol; 2004 Aug; 41(2):201-8. PubMed ID: 15288467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of organic anions in response to an early stage of renal ischemia-reperfusion in the rat: role of basolateral plasma membrane transporters and cortical renal blood flow.
    Di Giusto G; Anzai N; Endou H; Torres AM
    Pharmacology; 2008; 81(2):127-36. PubMed ID: 17971680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of organic anion-transporting polypeptide (Oatp) 1a1 and 1a4 null mice reveals altered transport function and urinary metabolomic profiles.
    Gong L; Aranibar N; Han YH; Zhang Y; Lecureux L; Bhaskaran V; Khandelwal P; Klaassen CD; Lehman-McKeeman LD
    Toxicol Sci; 2011 Aug; 122(2):587-97. PubMed ID: 21561886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age- and sex-related differences of organic anion-transporting polypeptide gene expression in livers of rats.
    Hou WY; Xu SF; Zhu QN; Lu YF; Cheng XG; Liu J
    Toxicol Appl Pharmacol; 2014 Oct; 280(2):370-7. PubMed ID: 25168429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravital multiphoton microscopy can model uptake and excretion of fluorescein in hepatic ischemia-reperfusion injury.
    Thorling CA; Liu X; Burczynski FJ; Fletcher LM; Roberts MS; Sanchez WY
    J Biomed Opt; 2013 Oct; 18(10):101306. PubMed ID: 23812606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways.
    Cheng X; Maher J; Dieter MZ; Klaassen CD
    Drug Metab Dispos; 2005 Sep; 33(9):1276-82. PubMed ID: 15919853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of phase II enzymes and transporters in futile cycling: influence of multidrug resistance-associated protein 2-mediated excretion of estradiol 17beta-D-glucuronide and its 3-sulfate metabolite on net sulfation in perfused TR(-) and Wistar rat liver preparations.
    Sun H; Zeng YY; Pang KS
    Drug Metab Dispos; 2010 May; 38(5):769-80. PubMed ID: 20124397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
    Bachmakov I; Glaeser H; Fromm MF; König J
    Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Human Intestinal and Hepatic Organic Anion Transporting Polypeptides: Where Is the Evidence for Its Relevance in Drug-Drug Interactions?
    Rodrigues AD; Lai Y; Shen H; Varma MVS; Rowland A; Oswald S
    Drug Metab Dispos; 2020 Mar; 48(3):205-216. PubMed ID: 31879282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of rat renal cortical organic anion transporter (OAT1 and OAT3) expression in response to ischemia/reperfusion injury.
    Zhang R; Yang X; Li J; Wu J; Peng WX; Dong XQ; Zhou SF; Yu XQ
    Am J Nephrol; 2008; 28(5):772-83. PubMed ID: 18441523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity.
    Cheng Q; Aleksunes LM; Manautou JE; Cherrington NJ; Scheffer GL; Yamasaki H; Slitt AL
    Mol Pharm; 2008; 5(1):77-91. PubMed ID: 18189363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats.
    Fisher CD; Lickteig AJ; Augustine LM; Oude Elferink RP; Besselsen DG; Erickson RP; Cherrington NJ
    Eur J Pharmacol; 2009 Jun; 613(1-3):119-27. PubMed ID: 19358839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.